Kalkine has a fully transformed New Avatar.
Company Overview: Maximus, Inc. (NYSE: MMS) specializes in business process services (BPS) for the health and human service industries. Its operating segments are 1) US Services Segment, which offers a variety of BPS, such as program administration, appeals and assessments, and related consultancy work to US state and local government programs, 2) US Federal Services Segment, which provides BPS solutions for a wide range of US federal civilian activities, including system and software development and maintenance and 3) Outside the US Segment, includes health and disability assessments, programme administration for employment assistance, and other job seeker-related services to governments and commercial customers in countries other than the US.
MMS Details
Key Takeaways from FY21 (ended September 30, 2021)
Revenues & Operating Profit Key Highlights; Analysis by Kalkine Group
Recent Developments
Segment Wise Results FY21
Balance Sheet & Liquidity Position
Key Metrics: In FY21, MMS's operating and net margins were 9.6% and 6.8%, higher than the previous annual of 8.3% and 6.2%, respectively. ROE stood at 21.4%, 1,560 bps more than the industry median. Debt/Equity was 1.02x as of September 30, 2021, significantly higher than 0.02x on September 30, 2020.
Profitability and Leverage Profile; Analysis by Kalkine Group
Top 10 Shareholders: The top 10 shareholders together form around 50.23% of the total shareholding, while the top 4 constitute the maximum holding. The Vanguard Group, Inc., and BlackRock Institutional Trust Company, N.A. hold the maximum stake in the company at 11.16% and 10.21%, respectively, as also highlighted in the chart below:
Top 10 Shareholders; Analysis by Kalkine Group
Risk Analysis
Outlook
Valuation Methodology: EV/Sales Based Relative Valuation (Illustrative)
Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company's FY1 trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: MMS's share price has corrected 18.70% over the past nine months. The stock is currently leaning towards the lower band of its 52-week range of USD 74.38 to USD 96.05. We have valued the stock using the EV/Sales multiple-based illustrative relative valuation method and arrived at a target price with an upside of high teens (in percentage terms). We believe that the company can trade at a premium compared to its peer's average, considering its strong cash flows, robust profitability margins and recent commercial contracts. We have taken peers like Concentrix Corporation (NASDAQ: CNXC) and International Money Express Inc. (NASDAQ: IMXI). Considering the strong top-line performance, robust profitability margins, growth across segments, associated risks, and current valuation, we give a "Buy" recommendation on the stock at the closing price of USD 77.15, up 0.55% as of January 14, 2022.
MMS Technical Chart, Data Source: REFINITIV
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decision should be made depending on the investors' appetite for upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the valuation has been achieved and subject to the factors discussed above.
Technical Indicators Defined
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and the uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.